Actionable trade ideas with defined risk and time horizons.
Curated trade ideas across equities, options, and other instruments, featuring clear directional bias, time horizon, and risk considerations. Trade ideas are designed to align market context, technical structure, and risk management principles.
13,707 total articles
DXP Enterprises (DXPE) is showing the mix and margin characteristics that can support a permanent move higher in valuation. With a market cap near $2.83B, EV/EBITDA about 16x and free cash flow of $118.7M, a sustainable ~12.2% adjusted EBITDA margin would justify a meaningful rerate. This trade idea outlines a clear entry, stop and target with a 18…
PRA Group (PRAA) trades at roughly 0.7x book and 0.55x price-to-sales while continuing to generate resilient cash collections from purchased nonperforming loan (NPL) portfolios. The balance sheet is levered and free cash flow is negative today, which explains the discount, but the mismatch between equity value ($732m market cap) and implied book (~…
POSCO Holdings is trading like a distressed steel name while quietly building exposures to EV battery materials, cathodes, recycling and infrastructure. At a market cap of $17.9B, a PB of 0.47 and a dividend yield around 2.4%, the stock offers an asymmetric risk-reward for a 180-trading-day trade if management execution on battery materials and ass…
Sezzle's latest quarter showed 51.7% revenue growth, 76% subscriber expansion and improving profitability. Price weakness in September has created a defined risk entry with upside to $145 if growth and merchant expansion continue. This trade targets a mid-term rebound over 45 trading days with tight risk control.
Coinbase looks well positioned to benefit from a renewed Bitcoin breakout and expanding institutional stablecoin partnerships. Valuation is rich on price-to-sales but supported by strong free cash flow and an enterprise value near $48B. This trade idea sets a clear entry at $192.25, stop at $170.00 and a $260.00 target on a mid-term swing (up to 45…
Molson Coors (TAP) trades at deeply discounted multiples and throws off strong free cash flow and a chunky dividend, yet it faces a secular beer-volume decline, material leverage and uneven recent results. This trade idea is a cautious, mid-term long that treats the stock as a value rebound candidate rather than a buy-and-forget income play.
Seanergy Maritime trades at a modest $355M market cap with a P/E of 5.7 and a 3.5% yield. The company’s Capesize-heavy fleet, shareholder-friendly payout, and a shallow float make the stock an asymmetric risk-reward. We rate SHIP Strong Buy and lay out an entry at $16.61, stop at $13.50 and a $24.00 target.
Zoetis is trading near its 52-week low after a string of execution concerns and legal headlines. With a market cap near $29B, EV/EBITDA ~9.0 and free cash flow of $2.37B, the stock offers a compelling risk/reward if you buy with discipline. This trade idea lays out an actionable entry at $70.50, a stop at $63.00, and a long-term target of $110.00, …
Rackspace (RXT) is being punished largely for GAAP losses and litigation noise tied to an AI strategy disclosure. The company still generates positive free cash flow ($41M), trades at a modest price-to-sales of 0.37 and has an enterprise-value-to-sales of 1.51. For traders who can tolerate headline risk, a mid-term swing long aims to capture a sent…
Advanced Micro Devices trades near $608 with a stretched valuation (roughly 155x earnings and 24x sales), but accelerating AI demand, new product wins and the recent World Labs acquisition preserve upside. This is a tactical mid-term long: enter on current strength or small weakness, use a protective stop below $550, and target $680 within 45 tradi…
Mizuho Financial (MFG) looks attractive after recent Bank of Japan tightening and management's investor day narrative. The stock trades near $11.07 with a reasonable P/E of 15.2 and PB of 1.9, a dividend yield of ~1.26%, and a market cap around $135.8B. We lay out a long trade with an entry at $11.00, a stop at $10.20 and a $12.50 target over a 180…
Sezzle's recent results show outsized subscriber and revenue growth with durable marketing ROI and improving unit economics. The market is pricing in caution after management signaled a marketing pullback; that creates a tactical opportunity to buy growth at a mid-teens multiple to durable free cash flow. This trade targets a return to re-rating if…
Sezzle's recent results and guidance show marketing ROI that supports profitable growth. Active subscribers jumped 76% YoY, revenue rose 51.7% in Q2 2026 and the company retains strong payback metrics. Technicals and short interest create a favorable risk/reward. I upgrade the rating and lay out an actionable long trade with entry, stop and targets…
AppLovin (APP) has been hit hard by concerns around its generative AI video rollout and weaker near-term revenue guidance. The pullback has pushed technical indicators toward support and trimmed valuations relative to peak sentiment. For disciplined traders, a mid-term long with tight risk control captures upside if advertiser spend and ROAS remain…
Western Digital (WDC) is a pragmatic way to play AI-driven storage demand without paying top-tier flash multiples. The company reported strong fiscal 2026 free cash flow ($3.51B), a modest net cash position (~$500M), and returned $3.1B to shareholders. With a market cap near $163.6B and a PE ~17.5x, WDC offers a mid-term asymmetric trade: buy on we…
Match Group (MTCH) combines durable cash flow, improving engagement at core products and a cheap earnings multiple. Recent results showed Hinge growth and raised Adjusted EBITDA guidance despite a modest revenue miss. For traders willing to own the stock for the next 45 trading days, the risk/reward favors a long with defined entry, stop and target…
Century Therapeutics is a pure-play allogeneic iPSC cell-therapy developer. Recent signs suggest competitors are narrowing the technological and commercial gap on its marquee approach. With limited public financial disclosure and binary program readouts ahead, this is a high-risk, high-reward short idea: entry $3.25, stop $4.75, target $1.50 over a…
UnitedHealth Group's underlying recovery - better medical cost trends, stronger Optum performance, and rising analyst earnings estimates - is underappreciated by the market. The stock sits below key moving averages and shows an RSI in the high-30s despite robust free cash flow ($23.6B) and an enterprise value of $381.3B. This trade targets an entry…
CoreWeave’s $104.2B backlog and raised 2026 revenue guidance argue that recent pricing moves are not slowing demand. The balance sheet and elevated interest costs are real headwinds, but near-term revenue visibility and improving technicals support a mid-term swing long. Enter at $86.44, target $120, stop $74.
Victory Capital (VCTR) is executing on scale and diversification: accelerating organic flows, a $7B First Eagle bolt-on, and attractive free cash flow give the stock room to run toward $126 over the next 45 trading days. Enter at $110.47, stop at $102.50, target $126.00. Risk is measurable - watch flows, acquisition execution, and fee compression.
Astera Labs supplies purpose-built connectivity silicon for rack-scale AI infrastructure. With record revenue growth, bold Q3 guidance and bullish technicals, ALAB offers an asymmetric payoff for growth-seeking traders — but the stock trades at premium multiples and carries execution and demand risks.
ProFrac looks like a classic cyclical recovery trade: improving U.S. fracturing activity should lift utilization and pricing, creating upside for a highly levered service provider. This is a cautious long with a clear stop - the reward hinges on operational recovery and visible deleveraging.
Argan is uniquely exposed to the electrification and data-center build cycle. Recent results show powerful top-line momentum and large free cash flow, while a pullback in the stock opens a tactical entry. We upgrade our stance and lay out an actionable long with precise entry, stop and target, plus balanced risks.
AECOM's core architecture & engineering franchise still works: record $27.8B backlog, double-digit backlog growth in several regions, and a visible pipeline in U.S. water and defense. Execution miscues produced a $337M legacy construction-management charge and weaker near-term cash flow, compressing the stock. For disciplined traders, a mid-term lo…
Credo is executing into AI-scale interconnects with a new 1.6T ZeroFlap optics family and a clear path to meaningful optical revenue. The stock has pulled back ~20% in a month despite blowout growth and margin strength. This trade buys that gap with defined risk controls while leaning on a mid-term catalyst calendar tied to customer ramps and optic…
